Category: CannabisNewsWire Release

Drink Companies Prepare for the Coming of CBD Beverages

CannabisNewsWire Editorial Coverage: CBD-infused beverages look set to hit the market in a big way in 2019.

  • Cannabidiol (CBD) is widely used in health and wellness products after spectacular growth in recent years.
  • Several companies are lining up to launch CBD drinks following legal changes in the United States and Canada.
  • Integrating these new offerings into wider product lines is accelerating CBD’s race for mainstream attention.

Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) is one of the first to launch, with a CBD coffee coming in May and a CBD water in the works. The Alkaline Water Company Inc. (NASDAQ: WTER) (TSX.V: WTER), which is constantly growing its U.S. distribution network, plans to add a CBD bottled water to its range. The New Age Beverages Corporation (NASDAQ: NBEV) is adding CBD to its line of organic cold coffees and teas. Heineken (OTCQX: HEINY) has also entered the market by developing a cannabis-infused sparkling water through Lagunitas, its U.S. craft brewer. And the biggest investment in the overall cannabis space has come from Constellation Brands Inc. (NYSE: STZ), which has invested $4 billion in a Canadian cannabis company.

To view an infographic of this editorial, click here.

Crossing the Boundary Between Two Industries

The most exciting new developments in business often come when separate trends or industries combine. For example, it was the combination of previously separate cameras, phones and portable music that brought us the smartphone, a technology that has transformed our lives. And while not every combination will be as socially disruptive as that computer in your pocket, each one brings new possibilities.

One of the hot crossover moves this year is the combination of the markets for beverages and for cannabidiol (CBD). The emergence of CBD over the past few years has transformed the cannabis space and allowed hemp producers to reach beyond their original markets. Beverages continue to be a powerful industry, in part through sporadic bursts of innovation such as the rise of energy drinks. Now one of those bursts is coming again as these two trends combine to produce CBD-infused drinks.

The Rise of CBD

In many ways, the popularity of CBD has caught businesses by surprise. Only a few years ago, it was an obscure chemical compound found in cannabis and hemp, not even the part of cannabis that got users high. Now it’s a newsworthy growth industry, with CBD products appearing on the shelves of health shops, pharmacists and vaping stores, as well as on dedicated online outlets. The trend has also led to the rise of new companies as well as investment from the likes of Youngevity International Inc. (NASDAQ: YGYI). CBD isn’t everywhere yet, but it’s feeling close.

Though it wasn’t predictable, the rise of CBD is easy enough to explain. Since cannabis legalization began in the 1990s, extensive research and development has been conducted regarding the plant. One of the results is a greater understanding of and focus on the range of chemicals found in cannabis, instead of just the high-inducing THC. As researchers started finding and reporting evidence that CBD could be beneficial for health and wellness, a gold rush began.

One of the big advantages of CBD, especially for an omnidirectional lifestyle company such as Youngevity, is that it can establish a strong presence in markets that THC can’t reach. Shops that don’t sell cannabis are sometimes willing to stock CBD-infused products. Some jurisdictions allow the sale of CBD but not cannabis. With the cannabis space gaining momentum, CBD creates a route into that sector with fewer restrictions.

This is particularly true because of hemp, a form of cannabis that doesn’t contain THC and that the federal government legalized three months ago. CBD can be extracted from hemp, making it a profitable cash crop. A Youngevity subsidiary has recently acquired a 45-acre base in Florida purely for the purpose of meeting the demand for CBD.

CBD Beverages

The U.S. government’s widespread legalization of hemp through the passage of the 2018 Farm Bill last December has opened the way for a whole range of CBD endeavors. One of the most popular trends is expected to be CBD beverages.

Youngevity, which already has a strong presence in both beverages and CBD via its CLR Roasters and HempFX brands, has made the most of its established expertise to move quickly into this promising young market. The company has added a CBD-infused coffee to its Javalution coffee brand, which will go on sale at the end of May.

“We are extremely pleased with the taste of the product,” said Ernesto Aguila, president of CLR Roasters. “It is very exciting to bring a new product to market that has so much interest within the coffee beverage category. I have not seen a door opener like this since Javalution Coffee Company created the first fortified coffees.”

CBD beverages are more than just a novelty; they’re a way to make CBD consumption better fit with people’s everyday lives and socializing, and to blaze a trail for cannabis drinks to follow. By putting CBD in drinks, manufacturers such as Youngevity are making it possible for consumers to enjoy their CBD in common social settings, such as cafes, bars and restaurants. While one person orders an alcoholic drink and another sips a soft drink, a third could be enjoying a CBD drink, all at the same time. YGYI’s move helps brings CBD consumption into the mainstream.

YGYI’s strategy has been made easier by the relaxed approach of the FDA. While that authority claims jurisdiction over the use of CBD in food and beverages, the government entity hasn’t done much to limit its use. In the 21st century, the public will to suppress cannabis use is fading, and resistance against CBD appears to be almost nonexistent. A door has been opened, and companies such as Youngevity are walking in to make the most of it.

The Bigger Beverage Business

Part of bringing CBD into the mainstream is integrating it with other product lines. As long as CBD is separate in its own corner, persuading people to give it a try will be challenging. However, when it’s presented as simply one more option among a variety of beverages, raising awareness and use of the substance stands a better chance. That’s precisely what Youngevity is aiming to do through a recently announced agreement with water company Icelandic Glacial.

The deal will see the two companies work together as exclusive cross-marketing partners for the next three years. Icelandic Glacial drinks will appear alongside Javalution and other beverages in Youngevity’s direct-sales network.

Beyond this, the companies will also collaborate on creating new products targeting the lifestyle, health, food and beverage markets. A drinkable CBD product will be at the forefront of these developments, creating a connection between the purity of Iceland Glacial’s water and the relaxing potential of CBD.

This deal hasn’t just increased Youngevity’s product range. It has given the company more opportunity for growth and product development that will appeal both to the core CBD market and to a wider beverage consumer base.

A Changing Drinks Market

It seems that CBD might become the latest big disruptor in the beverage industry, which was last shaken up by the rise of energy drinks 20 years ago.

The fastest growing premium water brand in the US, The Alkaline Water Company Inc. (NASDAQ: WTER) (TSX.V: WTER), is distributed through more than 150,000 stores, including nine of America’s top-ten retailers by size. In 2018, the company announced a range of drinks targeting the health and wellness markets, including a water infused with vitamins and minerals and another with CBD. The company is waiting on FDA approval before launching its CBD water, but once the product is ready to go, it will have great reach thanks to the company’s strategy of regularly increasing its distribution network.

Founded in 2016, the New Age Beverages Corporation (NASDAQ: NBEV) is a young and vibrant company with a focus on healthy drinks produced in an environmentally and socially responsible way. In January, the company announced a deal for the distribution of CBD-infused beverages under its Marley brand. The Marley range of organic cold coffees and teas is already an established brand for New Age Beverages and a natural fit for entering the CBD market.

Hi-Fi Hops, Heineken’s (OTCQX: HEINY) cannabis beverage, was launched last year in two versions: one with 10 mg of THC and one with 5 mg of THC and 5 mg of CBD. The product is sold in California’s cannabis dispensaries and is the result of a collaboration between AbsoluteXtracts, a manufacturer of cannabis-based products, and Lagunitas. “The idea of being a part of a no-calorie beverage infused with cannabis seemed like a perfect next step in our product innovation and a natural way to marry our past with our future,” said Lagunitas CEO Maria Stipp.

Beverage giant Constellation Brands Inc. (NYSE: STZ), which owns Corona beer and Svedka vodka, has made the biggest financial commitment so far to advancing CBD beverages. The company has invested $4 billion in Canopy Growth Corporation, one of Canada’s largest cannabis producers. The two companies will be working together to produce cannabis drinks, giving the sector a significant boost to its public profile thanks to Constellation’s marketing reach.

CBD drinks are a natural combination of two popular consumer sectors, and with so many companies invested in them, this looks likely to be the year they take off.

For more information on Youngevity, visit Youngevity International, Inc. (NASDAQ: YGYI)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – First Specialist Medical Marijuana Clinic Opens in the UK

Last Saturday (March 9) saw history being made in the UK as the first specialist medical cannabis clinic opened in Manchester. The clinic is called The Beeches Consulting Center.

The opening of this clinic has been widely welcomed by patients and clinicians in the UK. This cannabis clinic is owned by European Cannabis Holdings (ECH), a group of companies that plans to open many more such clinics across the UK.

The clinic will be headed by two respected professionals in the medical field. These are an independent pain specialist, Dr. David McDowell, and the second is a consultant neurologist, Professor Mike Barnes.

Dr. McDowell also holds the distinction of being the first specialist to issue a medical cannabis prescription in the UK when the British government enacted a law that made it possible for patients to access medical cannabis starting from December 1. 2018.

Forzana Nazir is one of the first patients that Dr. McDowell issued a medical cannabis prescription to. She is eternally grateful for this because she has been able to transition from taking 13 different medications for her genetic disorder to just three prescription medications ever since she started taking medical marijuana.

Nazir suffers from Ehlers Danlos Syndrome that made her nearly bedridden on a permanent basis due to the severe pain, vomiting and nausea. She credits medical marijuana for significantly improving her quality of life and also for weaning her off many prescription opioids.

The opportunities offered by this new clinic have huge significance given the difficulties that patients have been experiencing if they want to access medical cannabis through the NHS (National Health Service).

Patients are required to establish exceptional clinical circumstances, exhaust all the current treatment options available in the UK, get approval from an NHS Trust Medical Director and then get a medical specialist who is willing to accept liability for their medical cannabis treatment. Only then can a patient receive medical marijuana from the NHS. Any wonder that only four patients have so far accessed the NHS medical marijuana?

The clinic in Manchester, and others that will be opened, will offer an alternative to the complicated bureaucracy associated with getting medical marijuana through the NHS. For now, the clinic will treat chronic pain (due to arthritis, spasticity, fibromyalgia, etc.), psychiatric conditions (anxiety, depression, PTSD, etc.) and neurological conditions, such as Parkinson’s disease, Alzheimer’s, multiple sclerosis and epilepsy.

Net Element, Inc. (NASDAQ: NETE) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) congratulate ECH upon that major milestone of opening the first specialized medical marijuana clinic in the UK. That is a major investment which should open the eyes of other businesses to the massive opportunities that exist in the cannabis industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – British Lawyers Head to Brussels Over CBD Ban

Last month, we reported that there was a run on CBD drinks and other CBD products in the UK after the EU declared that CBD and other cannabis or hemp extracts were novel foods that could only be allowed on the market after receiving regulatory approval. Cannabis industry players in the UK aren’t taking that ban lying down. Their association has instructed a team of lawyers to head to Brussels in order to try and overturn that ruling.

While the EU law, (EU) 2015/2283, isn’t binding on the member states, many countries use the guidance provided by the EU to draft their own domestic laws and regulations. Actually, many EU countries promptly act on those recommendations then ask questions later.

For example, Austria immediately banned CBD and all food products containing it as soon as the EU made its ruling on the products.

Cannabinoids were categorized as novel foods by the EU since industry players “failed to prove” that those products had a history of being consumed in the EU prior to 1997 when the European Food Safety Authority (EFSA) was established.

Mackrell Turner Garrett, a London-based law firm, together with a leading trading standards and food attorney in the UK, have been sent to Brussels to meet EFSA officials in order to argue the case of the CBD industry in the UK.

The lawyers are acting on behalf of the Cannabis Trade Association UK and they will try to convince EFSA at the EU headquarters that since hempseed and hempseed extracts have already been approved, then they don’t belong in the category of the novel foods that should be banned.

This will be a tough fight to complete because the EU has a history of being cautious regarding any major global developments with origins in North America. This pushback has particularly been strong ever since the financial meltdown of 2008.

But the team from London is unfazed and wants to argue the case of its members. CBD has grown so rapidly that in just three years, the CTA (Cannabis Trade Association) has grown to more than 700 members.

Additionally, the CBD industry contributes approximately $130 million to the British economy each year. It remains to be seen whether the arguments presented by the lawyers will change the minds of the regulators in Brussels. Medical Cannabis Payment Solutions (OTC: REFG), MustGrow Biologics Corp. and other people who see investment opportunities hope that Brussels changes its stand so that the growth of the industry isn’t torpedoed at this point.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Workers’ Compensation Being Modified to Incorporate Medical Cannabis in Canada

You would expect that with more than 17 years of existence in Canada, medical cannabis should have already led to policy changes in various aspects of life in the country. However, if the claims of injured workers are anything to go by, workers’ compensation guidelines have been slow in changing to accommodate this form of treatment. Now matters are beginning to shift as the discussion below shows.

More Workers Winning in Tribunals

Mellissa Ellsworth is just one of 10 patients who have won hearings in Nova Scotia’s workers’ comp tribunal set up to assess whether the Workers’ Compensation Board should cover the cost of medical marijuana. It took her five years to get this approval.

Alberta’s board has so far also accepted to cover the medical marijuana costs of 10 workers who were injured on the job. New Brunswick shines in this regard because it has so far approved 71 patients’ applications for medical cannabis costs coverage under workers’ comp policies.

It is saddening that patients have to endure years of pain as their applications slowly make their way through the red tape of the Workers’ Compensation Boards in the different provinces and territories. For example, the neurological pain experienced by Melissa Ellsworth led her to take a total of 26 pills on a daily basis just to function as a normal human. She now takes only cannabis and enjoys a better quality of life.

The good news amidst all this is that for each patient who gets approval, more are encouraged to table their requests before the different boards. Eventually, medical cannabis will become a normal form of treatment and no patient will have to go through what the pioneers like Melissa Ellsworth had to endure to get approval.

Doctors’ Prescriptions Rarely Considered

You would think that the different Workers’ Compensation Boards would attach some weight to the recommendations provided by the primary healthcare providers of the patients who apply for coverage.

However, only Quebec recognizes and acts upon those recommendations. Other boards convene their own medical team sittings to assess the eligibility of a patient for medical cannabis. Why should this happen when Health Canada screens patients before giving them a medical cannabis card?

Caps on Daily Cannabis Consumption

Nearly all provinces and territories that are even willing to consider paying for medical cannabis for injured workers impose a three gram cap on how much medical cannabis a patient can claim coverage for each day.

While there may be valid reasons for this cap, it would be reasonable for these boards to acknowledge that different patients have different needs, so mechanisms should be available for those who need more to be covered without major hassles. Even Health Canada allows patients to grow hundreds of cannabis plants if they need a lot on a daily basis for their treatment. But, workers’ comp boards still insist on three grams a day!

But, There’s Progress…

Amidst this huge cloud hovering over injured workers in Canada, winds of change are slowly picking up. Last year, New Brunswick set the stage by passing medical cannabis guidelines. Prince Edward Island followed suit, and now Nova Scotia is drafting its own set of guidelines.

While all this is happening in Canada, one wonders what the situation is here in the U.S. With most marijuana businesses still struggling to access banking services, it is hard to picture what patients may be going through if they wish to have their medical cannabis costs covered by workers’ comp insurance. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America (OTCQB: MCOA) decry the slow rate at which workers’ compensation is evolving to accommodate medical cannabis. This isn’t only denying patients a viable treatment option, but it is also limiting the investment opportunities that would boost the economy.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Demand Soars for Missouri Medical Cannabis Licenses

The cannabis bullet train doesn’t seem to be showing any signs of slowing down in Missouri ever since voters overwhelmingly passed a ballot measure in the recent midterms to legalize medical marijuana in the state. Now more than 300 businesses are due to be licensed to participate in the medical cannabis industry once it is commercialized.

This announcement was made by Lyndall Fraker, the Missouri Medical Marijuana Program Director, while speaking at a medical marijuana conference in St. Louis on Monday (March 11). He added that if those 300 licenses weren’t enough, then the state wouldn’t hesitate to grant more to the businesses that wish to serve Missouri patients in different capacities.

Already, more than 450 applications have been received from entities that would like to cultivate, manufacture, dispense or test medical marijuana and its products in the state. It is from this pool that the state will select the first 300 businesses to be licensed.

For now, the regulator has set the minimum number of players that will operate in the different segments of the medical marijuana industry. These include at least 192 dispensaries, two marijuana testing facilities, 85 manufacturing facilities and 60 marijuana cultivation facilities.

When added up, those figures exceed the 300 licenses that will be awarded initially, so you can see that the state already has plans for an extensive and robust medical cannabis industry.

You may be wondering, won’t 300 businesses be too many for an industry that is just being set up? This concern may be legitimate, but if anything is to be learnt from the Canadian recreational cannabis industry, it is risky to allow only a few players in the industry.

The cannabis shortages in Canada can largely be explained by the country’s failure to license enough businesses to participate in the different aspects of the cannabis value chain. The resulting mess will possibly take years to fix. Missouri may therefore be onto something when they start off with hundreds of licensed businesses.

Besides, not all of those 300 businesses will start operations at the same time. And when they do start, not all of them will be successful. Others will close shop while more will merge with other businesses.

It is therefore a good thing that the state intends to give all those businesses a shot and then their fate will be squarely in their hands once they get hold of a license. Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), Green Hygienics Holdings Inc. (OTCQB: GRYN) and all who wish to invest in the medical cannabis industry welcome the steps being taken by the Missouri Medical Marijuana Program to do things right from the get-go.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Savvy Companies Seizing Opportunities in Growing Cannabis Market

CannabisNewsWire Editorial Coverage: As the cannabis industry expands, companies are eyeing strategic opportunities in the sector designed to help them establish a foothold in the promising space.

  • Cannabis and related products are legal in Canada and an increasing number of states.
  • Businesses have responded with a growing range of diverse products.
  • Companies making the smartest investments, including carefully selected mergers and acquisitions, are in the best position to profit.

SinglePoint Inc. (OTCQB: SING) (SING Profile) has invested in a number of other cannabis companies to grow its portfolio and leverage its position in the market. Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) just signed of letter of intent with Malta Enterprises, the economic development agency of Malta. MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) recently wrapped up its previously announced acquisition of Kannaboost Technology Inc. and CSI Solutions LLC, two vertically integrated Arizona-based operations. Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) reported more than 10 times growth in harvested hemp compared to its 2017 grow season. And Curaleaf Holdings Inc. (OTCQX: CURLF) (CSE: CURA) has signed a definitive agreement to acquire Eureka Investment Partners LLC.

To view an infographic of this editorial, click here.

A Big Year for Big Investment in Cannabis

In only a few short weeks, this year is shaping up to be an important year in the cannabis market. The legal groundwork for industry changes was laid last year, with milestone legislation being passed in Canada, the United States and elsewhere. With legal regulations in place, new opportunities for the market to grow and for companies to make strategic moves within the sector have become more frequent — and appear to be more profitable.

This upward movement is fueling the ongoing development of two important trends: The first one is product diversification, as cannabis companies and the businesses supporting them develop a wider range of products for an increasingly varied market. The second one is big investment, as both outside businesses and larger cannabis companies move to create a presence in the market. Money is flowing in, making the most of the opportunities that legal and product changes provide.

A Changing Global Context

This year’s promise is rooted in last year’s significant growth and impressive forecast. SinglePoint Inc. (OTCQB: SING), a young tech company that has moved into the cannabis sector, saw its revenue hit the $1 million mark. In addition, like many cannabis companies, the company ended the year with even better things on the horizon, including a prediction that revenue should dramatically increase over the next 12 months.

Making such claims in a relatively untried sector may seem bold, but closer scrutiny reveals why such predictions appear to be solid.

To begin with, the changing attitude of lawmakers to cannabis has been crucial to the industry’s forward momentum. The prohibitory model for managing the drug that has dominated for half a century is increasingly recognized as not just ineffective but harmful to public health. As a result, governments are legalizing cannabis for medical use and are even creating regulated markets for recreational cannabis. This is especially true in Canada, where the trade became legal countrywide last October.

For American companies such as SinglePoint, progress has come on a state-by-state basis. Though the majority of Americans favor legalization, the federal government has been slow to follow what appears to be a nationwide attitude. Instead, individual states have created legal markets, with Michigan becoming one of the most recent with cannabis legalization taking place there in December. Two-thirds of U.S. states now allow medical cannabis, and one in five have legalized its recreational use; more are expected to follow suit in the near future. This swing in attitude — and government support — has allowed SinglePoint to begin investing in cannabis without having to consider a national cannabis business.

The end of the year saw a significant step towards wider legalization. Following months of wrangling, the 2018 Farm Bill was passed making industrial hemp legal on the federal level. This nonpsychoactive from of cannabis has provided many companies, including SinglePoint, with an important entry point into the sector, as the chemical cannabidiol (CBD), which can be derived from hemp, can be more widely sold than other forms of cannabis. CBD’s impressive popularity has provided a further boost to the sector, especially to companies entering the industry with CBD offerings.

Undoubtedly, the Farm Bill is set to allow cannabis businesses to grow significantly through hemp and provide a precedent as federal politicians reconsider the wider cannabis industry.

Product Diversification

Now that companies have identified CBD as a promising step into the market, they are doing what they do best — finding new ways to sell their products and services. This has led to a wave of innovation and an increasingly diverse range of cannabis-based products.

Two of the biggest areas for innovation are the creation of confectionaries and beauty products. The former offers a way to consume cannabis without inhaling it. The latter appears to be a natural fit given the suggested well-being benefits of CBD and THC, along with the willingness of customers to try new plant-based beauty products. But innovative companies aren’t stopping there, with options such as Phyto-Bites, a product SinglePoint distributes on its website SingleSeed.com, designed to improve the health and well-being of pets.

Human health and well-being remain a huge driver for innovation in cannabis. Aware of that, SinglePoint has also been adding health and wellness products to its sales lines. Its SingleSeed store recently unveiled a range of TorusMed Hemp CBD products to its offerings. The new products include treatments such as Sport Relief Topical Cream, an ointment designed to provide pain relief for professional and amateur athletes.

Smart Investing in the Cannabis Sector

The growth of the cannabis sector has not occurred without a few bumps along the way. Companies are operating in a space that didn’t even exist 20 years ago, and the sector is evolving quickly, with the last few years triggering a wave of consolidation. In a fast-changing market, challenges are expected, and the ability to meet such challenges successfully is essential to a company’s success.

The secret to smart investing in this new space is the same as for any sector: research, understand the businesses being invested in, identify a plan and execute it. Understanding the specifics of the cannabis market is critical, and the trend within the industry most recently has been mergers and acquisitions, as companies such as SinglePoint have expanded through investment in promising companies that provide products and services that will complement and support its strategy.

SinglePoint’s most recent investment has been in TorusMed, a company developing new ways to optimize CBD output from hemp and, consequently, increase the profitability of this piece of the cannabis sector. With the Farm Bill pointing to hemp creating a new boom in the industry, SinglePoint has used its understanding of the market to invest in a company that appears to offer great potential to make the most of this moment.

Moves such as this can put a company in a strong position heading into what may be the biggest year yet for cannabis. “[This year] will be a banner year for SinglePoint,” said SinglePoint CEO Greg Lambrecht. “We are equipped with the proper funding, partners and opportunities to be firing on all cylinders. We as a team expect to position SingleSeed and SinglePoint as market leads in the CBD market while continuing to enable the founders of the companies we have acquired to grow their businesses. We are well diversified and have large opportunities across many emerging markets that should enable us to be successful into 2019 and beyond.”

New Year, Fresh Growth

The move for Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) to partner with Malta Enterprises is the company’s first step to obtain a Cannabis Production License in the country. The license would allow Supreme to produce and process cannabis for medical use within Malta, one of Europe’s principal commercial entry points, and to export cannabis for medical use to certain international markets.

MedMen Enterprises Inc.’s (CSE: MMEN) (OTCQX: MMNFF) acquisition of Kannaboost Technology and CSI Solutions LLC includes retail locations in Scottsdale and Tempe, as well as 25,000 square feet of cultivation and production capacity in Tempe and Phoenix. The acquisition also includes a 40-percent stake in top-selling brand K.I.N.D. Concentrates, which is currently distributed in more than 90 percent of Arizona dispensaries.

Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) claims the No. 1 position in market share in the hemp CBD market, with its products sold in 3,680 retail locations as well as on its website. Charlotte’s Web had 300 acres of hemp planted in 2018 compared with only 70 acres in 2017, resulting in a harvest of 675,000 pounds of hemp last year. The legalization of hemp in the U.S. should open the doors for Charlotte’s Web to expand its retail opportunities with national chains.

Curaleaf Holdings Inc.’s (OTCQX: CURLF) (CSE: CURA) definitive agreement to acquire Eureka Investment Partners will provide access to California’s wholesale market through an existing 110,000-square-foot greenhouse facility in Salinas, California, with the potential to expand up to 270,000 square feet, which could generate more than 50,000 pounds of dry flower per year at full scale. Headquartered in Massachusetts, Curaleaf has a presence in 12 states, owns and operates 42 dispensaries, 12 cultivation sites and 10 processing sites with a focus on highly populated, limited-license states including Florida, Massachusetts, New Jersey and New York.

Legal changes are encouraging an increasingly diverse cannabis market, in which companies that make smart investments are primed for profit.

For more information on SinglePoint, visit SinglePoint Inc. (OTCQB: SING)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Cerebral Palsy Added to Michigan Medical Cannabis Qualifying Conditions

Voters approved a ballot measure in 2008 to legalize medical cannabis in Michigan and since then, the list of the qualifying conditions has been expanding slowly. Cerebral palsy is the latest condition to be added onto that list which has just over two dozen health conditions.

LARA (the Department of Licensing and Regulatory Affairs) made the announcement after its sitting to consider the different conditions which had been proposed for inclusion on the list of medical marijuana qualifying conditions. LARA rejected requests to include Chronic Aggressive Behavior among the conditions that can be treated or managed using medical marijuana.

Cerebral palsy, a neurological disorder, develops when the brain of a child gets injured during its developmental stage. Some of the symptoms that can result from this condition are lack of motor function and control. There is evidence that marijuana can help to reduce the spastic movements or the seizures experienced by people suffering from cerebral palsy.

According to the statistics of the United Cerebral Palsy Foundation, about 764,000 people are affected by this disorder in the U.S. Most of those individuals (500,000) are kids that are less than 18 years of age.

It is therefore a big help that cerebral palsy has been added to the list of qualifying conditions in Michigan since conventional medicine offers little help to people suffering from this condition.

It is hoped that more people will now be able to get medical cannabis cards from the state. Currently, 294,000 people are registered and have medical marijuana cards in Michigan.

Accessing the medical marijuana program doesn’t have any age restriction, and many kids with various conditions, such as seizures, are cardholders in the state. The only extra requirements for kids is that a minimum of two doctors should recommend them to start using medical cannabis and the parent or guardian of that minor has to give consent for the child to start taking medical marijuana.

Last year, Michigan voters approved a ballot measure to legalize recreational cannabis. Adult-use cannabis will only be available to those who are at least 21 years old. Plans are underway to set up a regulatory system for the recreational sector, but the medical cannabis program will remain intact.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) and Generation Alpha, Inc. (OTCQB: GNAL) applaud the progressive approach taken by LARA which will allow patients and investors in Michigan to benefit from cannabis as the industry evolves.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Delaware Considers Letting Doctors Prescribe Cannabis for Most Ailments

Senator Anthony Delcollo has introduced a bill in the state senate to change the law so that doctors will be free to decide which patient would be helped by medical marijuana instead of first checking whether that patient has a condition listed in the medical marijuana law.

Under the current law which was passed in 2011, patients can only qualify to get onto the medical marijuana program if they have one of the “debilitating conditions” such as terminal illnesses and cancer.

Delcollo argues that doctors undergo extensive training and have a lot of experience in the field. These professionals should be given the liberty to decide what is in the best interest of their patients, he says.

Senate Bill 24 is therefore intended to free doctors to use their discretion in determining whether medical cannabis will provide “palliative or therapeutic benefit” to patients.

The senator argues that this wouldn’t be a new thing since doctors are already exercising their professional discretion to determine which pharmaceuticals on the market are most likely to be beneficial to their patients.

Medical cannabis advocates concur and say that the proposed change is long overdue. They add that it should have been part of the first law that legalized medical marijuana in the state in 2011.

The bill is also intended to ease the restrictions on the kinds of medical specialists that are authorized to recommend the use of medical cannabis by patients who are younger than 18. However, the change would not alter the current provision stating that patients who are less than 18 can only use cannabis oil and not any other form of medical marijuana.

Senate Bill 24 enjoys bipartisan sponsorship and support, so it is hoped that the lawmakers will debate it thoroughly and give it the nod.

If it passes, Delaware will join Oklahoma and Maine as the only states that give doctors such leeway in deciding who can or cannot be treated using medical marijuana.

It hasn’t been an easy journey for Delaware to get to this point. It should be recalled that there were endless delays in opening the compassion centers where patients could access medical cannabis. To date, only four such centers are operational in the state.

More recently, there were plans to legalize recreational marijuana legislatively. More than a year was taken to debate the bill and when a vote was called, the bill was defeated by just four votes in June last year. No other recreational marijuana bill has yet been tabled during this legislative session.

Be that as it may, Global Payout, Inc. (OTC: GOHE), Golden Developing Solutions, Inc. (OTC: DVLP) and the entire investment community are hoping that this time round, appropriate legislation improving the medical cannabis environment is passed so that all interested parties, such as patients, can benefit.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Georgia House Votes to Allow Medical Cannabis Oil

The Georgia House of Representatives voted last week (March 5) and passed a bill intended to regulate the manufacture and sale of medical marijuana oil. This bill now goes to the state senate for consideration before it becomes law.

The existing regulations in Georgia don’t allow the cultivation, manufacture or sale of cannabis oil, and this has left patients using medical marijuana in the state with no source of cannabis oil even if the laws allow the use of that oil as long as its THC content doesn’t exceed 5 percent.

House Bill 324 is geared at changing that so that patients who enroll on the medical cannabis program can access medical cannabis oil.

Once the bill is enacted into law, the 8,400 patients who have so far registered in the medical cannabis program of the state will be able to buy cannabis oil from one of the 60 medical marijuana dispensaries in the state.

Allan Powell, the Republican chair of the committee that initially considered the bill before sending it to the entire House for a vote, said that he was happy that a legal avenue was being created for qualifying patients to access marijuana oil.

He added that it was hypocritical to pass a law stipulating what kind of cannabis oil patients should use yet no mechanism was put in place to make it possible for patients to access that oil.

House Bill 324 sets the bar high for companies that would like to participate in the medical cannabis industry of the state. For example, large companies will have to pay $150,000 for a license while smaller companies will have to fork out $37,000. It will cost $30,000 to get a license to operate a medical cannabis retail business.

Renewing those licenses will not be any easier either. The fees for this range between $10,000 and $50,000. The businesses had better attract a large volume of sales if they are to thrive despite these high license acquisition and renewal fees.

Meanwhile, the bill still has opposition outside the chambers of the lawmakers. For example, the Georgia Sheriffs’ Association led by Terry Norris has described the bill as something that will take the state down a dangerous and treacherous path that may end into kids using marijuana while adults will eventually switch from cannabis to more dangerous drugs.

Such scaremongering isn’t new, but it may amount to nothing since even the Governor has promised to sign the law once it is passed by the senate. Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and ChineseInvestors.com (OTCQB: CIIX) hope that the legislation will be passed and implemented expeditiously so that patients and investors don’t have to wait any longer than is necessary for them to access medical cannabis oil or the opportunities the industry offers.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – The UN Announces Yet Another Delay of its Cannabis Reclassification Vote

First, the World Health Organization (“WHO”) delayed and postponed the release of its recommendations after an expert committee studied proposals for the reclassification of cannabis in international treaties. Now, yet another delay has hit that activity and the UN has announced that the March sitting of the UN Commission on Narcotic Drugs, and the one in December this year, will not have marijuana reclassification on its agenda.

The recommendations of WHO had initially been scheduled to be voted on in December last year, but this was inexplicably postponed.

Some of the 53 members of the Narcotic Drugs Commission reportedly claimed that they needed additional time to study the recommendations made by the World Health Organization before they can decide how to vote when a vote is called.

Other members, such as Uruguay and Norway, were disappointed that no timeline was set for when the recommendations will be considered and voted upon. There are fears that the matter may be put on the backburner for an indefinite amount of time, for political reasons.

The recommendations were widely seen as a way for many countries to be free to embark on medical cannabis research and legalization, with others taking it a step further and decriminalizing adult-use marijuana.

The WHO had recommended that whole-plant marijuana and its resin should be removed from the strictest category (Category 4) of the 1961 International Drug Convention and placed in a less restrictive category.

To put this into perspective, the U.S. system of categorizing controlled substances is different from that of the UN. For example, in the U.S., Schedule 1 is reserved for the substances that deserve the strictest controls and the restrictions reduce as the schedule number gets bigger. This is unlike the UN where the smaller numbers have fewer restrictions while the bigger numbers, such as Category 4, have more stringent restrictions.

Meanwhile, as the UN is still playing hide and seek regarding its position on the calls for marijuana rescheduling, Europe is taking a different path. The EU Parliament approved a resolution calling on member states to avail support and funding for medical cannabis research. While the decision isn’t binding, it could pave the way for widespread research and legal reforms in EU member countries. This will leave the U.S. further behind in the rapidly evolving cannabis industry.

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) and Earth Science Tech, Inc. (OTCQB: ETST) call on the UN to stop dragging its feet and make the decision for which the world has been waiting.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com